Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis - Woolen, S A; Shankar, P R; Gagnier, J J (JAMA Intern Med, 2020)